Loading organizations...
Loading organizations...
Biosimilar monoclonal antibodies and therapeutic proteins development.
Epirus Biopharmaceuticals has raised $36.0M across 1 funding round.
Epirus Biopharmaceuticals has raised $36.0M in total across 1 funding round.
Epirus Biopharmaceuticals has raised $36.0M in total across 1 funding round.
Epirus Biopharmaceuticals's investors include Daotian Fu, 5AM Ventures, Adage Capital Management, Gibralt US, Greenwoods Investment, Monashee Investment Management, Montreux Equity Partners, Mousse Partners, TPG Biotech.
Epirus Biopharmaceuticals has raised $36.0M across 1 funding round. Most recently, it raised $36.0M Series B in April 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 16, 2014 | $36.0M Series B | Daotian Fu | 5AM Ventures, Adage Capital Management, Gibralt US, Greenwoods Investment, Monashee Investment Management, Montreux Equity Partners, Mousse Partners, TPG Biotech |